Skip to main content
BL Pharmtech Corp. logo

BL Pharmtech Corp. — Investor Relations & Filings

Ticker · 065170 ISIN · KR7065170003 KO Manufacturing
Open in API
Filings indexed 278 across all filing types
Latest filing 2025-02-27 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 065170

About BL Pharmtech Corp.

http://www.blpharmtech.com/

BL Pharmtech Corp. is a healthcare company that manufactures, distributes, and sells health functional foods, dietary supplements, and nutraceuticals. The company's portfolio also includes cosmetics, food additives, and pharmaceuticals. A significant part of its operations is dedicated to biotechnology and bio-pharmaceutical research and development. Through its Daedeok Research Institute and in collaboration with subsidiaries BL Melanys and BL Science, the company partners with academic institutions, including KAIST and Columbia University Medical Center, to advance its research initiatives.

Recent filings

Filing Released Lang Actions
전환가액의조정
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system titled '전환가액의조정' (Adjustment of Conversion Price). It details the adjustment of conversion prices for convertible bonds (19th and 20th series) due to a bonus issue (무상증자). This type of filing is a standard corporate disclosure regarding capital structure and financial instruments, which falls under the 'Regulatory Filings' category as it is a specific disclosure of a corporate event that does not fit into the other specialized categories like M&A, Dividends, or Share Repurchases.
2025-02-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders (Park Young-chul and special related parties) due to a bonus issue (free share distribution). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and changes.
2025-02-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when company insiders (executives or major shareholders) change their shareholdings. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers insider transactions and changes in ownership status by company directors and executives.
2025-02-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This document details the change in share ownership for an executive (Shin Dong Jin) due to a bonus issue (무상증자). In the provided classification schema, reports of personal share transactions by company directors and executives are categorized as 'Director's Dealing' (DIRS).
2025-02-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding changes of an executive (Song Sang-guen) at BL Pharmtech due to a bonus issue (무상증자). This is a standard regulatory filing for insider shareholding changes, which falls under the 'Director's Dealing' category.
2025-02-27 Korean
권리락 (무상증자)
Share Issue/Capital Change Classification · 1% confidence The document is a short announcement regarding a 'rights offering' or 'ex-rights' (권리락) event due to a bonus issue (무상증자) for the company BIEL Pharmtech. It provides specific details like the reference price and the effective date. This falls under capital changes and share issuance announcements, which is best categorized as SHA (Share Issue/Capital Change).
2025-02-25 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.